Skip to content
Government Federal, Medical Health Aged Care

Engineered stone ban a great step, but go further on silica’s harms: PHAA

Public Health Association of Australia < 1 mins read

13 December 2023

The country’s peak body for public health welcomes the announcement of the ban of engineered stone in Australia, following a decision from the country’s Work Health and Safety Ministers. 

“We congratulate the Ministers for supporting the recommendation by SafeWork Australia and all the researchers, clinicians, and unions who fought for this important world leading reform,” Public Health Association of Australia (PHAA) CEO, Adj Prof Terry Slevin said.

“Most importantly, we thank and recognise the workers themselves, who suffered silicosis and other respiratory conditions, for fighting for the rights of those who follow them, to avoid the same fate.

“The extreme levels of silica in these products has led to an enormous increase in tradespeople working with these products having their lungs irreparably damaged. This was unequivocally caused by using these products, in their normal work. That cannot and should not continue, so this ban shows the system can work.

“This is an important day to be celebrated.

“But it is also a call to action to work harder to reduce the known burden of those who, in their daily work are exposed to silica, and other substances injurious to the health of those who are exposed to them. 

“Engineered stone is the most obvious and clear example of a dangerous product. There are others. Perhaps less immediate in their impact, perhaps less potent, but still unfairly stealing the good health of honest, hard-working people in Australia. 

“Efforts to reduce that harm to make work – all work – safer and healthier remain an important priority.”



For further information/comment:

Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917,  

Contact details:

Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917,  


More from this category

  • Medical Health Aged Care
  • 04/03/2024
  • 11:16
Ego Pharmaceuticals

$30,000 to be won | QV Healthcare Practitioner Student Scholarship Back For 2024

Opening on March 4th 2024, the QV Healthcare Practitioner Student Scholarship will award a total of $30,000 in prize money to undergraduate and postgraduate…

  • Contains:
  • General News, Medical Health Aged Care
  • 04/03/2024
  • 10:55
Breast Cancer Network Australia

6 Key Breast Cancer Drugs Now More Affordable Thanks to 60-day Prescribing

04/03/2024 Breast Cancer Network Australia (BCNA) welcomes six common drugs used to treat breast cancer being able to be prescribed and dispensed for 60-days with a single prescription. The drugs include common types of hormone blocking therapies such letrozole, anastrozole and tamoxifen, amongst others, which combined represented almost one million individual prescriptions in the 2023 calendar year. These drugs are included in the second tranche of over 300 medicines that have moved to 60-day prescribing since it was announced in September last year. The six hormone blocking drugs are used to treat hormone receptor positive breast cancer. Hormone blocking therapy,…

  • Medical Health Aged Care
  • 04/03/2024
  • 09:00
Dementia Australia

Dementia Australia supports Geraldton

Are you concerned about your memory or worried that someone you know may have dementia? Dementia Australia is offering support in Geraldton between 18 March and 21 March. It is estimated there are more than 41,400 people living with dementia in Western Australia. Without a medical breakthrough this number is expected to increase to more than 86,800 people living with dementia by 2054. The Dementia Australia sessions are an opportunity for people living with dementia, their carers, family, and friends to attend free education to better understand dementia and to discuss the support and services Dementia Australia can provide. Please…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.